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Summary. Thyrotropin-releasing hormone (TRH)
synthesized in the hypothalamus has the capability of
inducing the release of thyroid-stimulating hormone
(TSH) from the anterior pituitary, which in turn
stimulates the production of thyroid hormones in the
thyroid gland. Immunoreactivity for TRH and TRH-like
peptides has been found in some tissues outside the
nervous system, including thyroid. It has been
demonstrated that thyroid C-cells express authentic
TRH, affecting thyroid hormone secretion by follicular
cells. Therefore, C-cells could have a paracrine role in
thyroid homeostasis. If this hypothesis is true, follicular
cells should express TRH receptors (TRH-Rs) for the
paracrine modulation carried out by C-cells. In order to
elucidate whether or not C-cell TRH production could
act over follicular cells modulating thyroid function, we
studied TRH-Rs expression in PC C13 follicular cells
from rat thyroid, by means of immunofluorescence
technique and RT-PCR analysis. We also investigated the
possibility that C-cells present TRH-Rs for the autocrine
control of its own TRH production. Our results showed
consistent expression for both receptors, TRH-R1 and
TRH-R2, in 6-23 C-cells, and only for TRH-R2 in PC
C13 follicular cells. Our data provide new evidence for a
novel intrathyroidal regulatory pathway of thyroid
hormone secretion via paracrine/autocrine TRH
signaling.
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Introduction
Thyrotropin-releasing hormone (TRH) is a tripeptide
(pGlu-His-ProNH2) synthesized from a larger
polypeptide precursor which yields five copies of TRH
and seven non-TRH peptides (Lechan et al., 1986). This
hormone was originally isolated from mammalian
hypothalamus and has the capability of inducing the
release of thyroid-stimulating hormone (TSH) from the
anterior pituitary. TRH binds to a specific receptor, the
TRH receptor (TRH-R), which belongs to the large
family of G protein-coupled receptors with seven
transmembrane domains. 
Two subtypes of TRH-Rs have been cloned, TRH-
R1 and TRH-R2. The first one was originally cloned
from a mouse thyrotropic pituitary tumor (Straub et al.,
1990) and then from rat (Zhao et al., 1992; De la Pena et
al., 1992; Sellar et al., 1993), human (Matre et al., 1993;
Duthie et al., 1993; Yamada et al., 1993), chicken (Sun
et al., 1998), bovine (Takata et al., 1998), lower
vertebrate (Harder et al., 2001), and amphibians (Bidaud
et al., 2002) tissues. TRH-R2 has been cloned from rat
spinal cord complementary DNA (cDNA) library (Cao
et al., 1998), rat brain cDNA libraries (Itadani et al.,
1998; O’Dowd et al., 2000), mouse brain (Harder et al.,
2001), and frog brain (Bidaud et al., 2002). TRH-R1 and
TRH-R2 bind agonists with indistinguishable affinities
and both signal via the phosphoinositide pathway
(Harder et al., 2001). In contrast, the two receptor
subtypes exhibit different tissue expression (Cao et al.,
1998; Heuer et al., 2000; O’Dowd et al., 2000) and
TRH-R2 exhibits a much higher basal activity than
TRH-R1 does (Wang and Gershengorn, 1999). TRH-R1
is found in high abundance in the anterior pituitary and
is mainly involved in the signaling of TRH within
neuroendocrine brain areas, but it exhibits only a very
limited mRNA expression pattern in other regions of the
central nervous system (CNS) (Calzá et al., 1992;
Zabavnik et al., 1993; Heuer et al., 1998). Northern blot
analysis and in situ hybridization data reveal that TRH-
R2 is expressed exclusively in rat brain and spinal cord
(Cao et al., 1998; Heuer et al., 2000); although it has
also been detected in pituitary (O´Dowd et al., 2000).
Recently, a novel subtype of TRH receptor, TRH-R3,
has been identified in Xenopus laevis brain (Bidaud et
al., 2002); although a posterior study suggests that this
TRH-R3 is a receptor for a ligand other than TRH (Lu et
al., 2003).
Thyrotropin-releasing hormone receptor expression in
thyroid follicular cells: a new paracrine role of C-cells?
M. De Miguel1, J.M. Fernández-Santos1, J.C. Utrilla1, 
A. Carrillo-Vico2, J. Borrero2, E. Conde1, J.M. Guerrero2 and I. Martín-Lacave1
1Departament of Normal and Pathological Histology, and 
2Departament of Biochemistry and Molecular Biology, Faculty of Medicine, University of Seville, Seville, Spain
Histol Histopathol (2005) 20: 713-718
Offprint requests to: Inés Martín-Lacave, Dpto. Citología e Histología
Normal y Patológica, Facultad de Medicina, Universidad de Sevilla,




Cellular and Molecular Biology
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by idUS. Depósito de Investigación Universidad de Sevilla
Besides stimulation of TSH secretion at the pituitary,
additional endocrine functions of TRH have been
demonstrated; its strong effect as a prolactin
secretagogue and its ability to stimulate the secretion of
growth hormone (GH) under certain, mainly
pathological, conditions. On the other hand, numerous
morphological and pharmacological studies have
implicated TRH as playing a role as neurotransmitter or
neuromodulator in the CNS affecting behavior,
temperature regulation, food intake, and nociception
(Griffiths, 1985; Horita et al., 1986; Kelly, 1995; Cao et
al., 1998; Horita, 1998; Nillni and Sevarino, 1999). 
Although TRH have been tested in hypothalamus
(over 70% of the total brain) and extrahypothalamic
brain areas (Prasad, 1984), TRH or TRH-like
immunoreaction for this hormone have been found in
some tissues outside the nervous system such as
prostate, pancreas, testis, adrenal gland, and thyroid
(Morley, 1979; Jackson, 1982; Pekary et al., 1983, 1986;
Iversen et al., 1984; Montagne et al., 1997, 1999).
Moreover, in the case of thyroid, it has been well
established that C-cells express true TRH at both mRNA
and protein levels (Gkonos et al., 1989). 
It has also been demonstrated that TRH inhibits the
release of thyroid hormones and the increase of cAMP
induced by TSH from dog thyroid (Delbeke et al., 1983;
Iversen and Laurberg, 1985). Although the effect of
TRH on thyroid hormone secretion could be due to
hypothalamic TRH, C-cells could have a paracrine role
in thyroid homeostasis by virtue of their own TRH
synthesis. This paracrine role of C-cells could also
explain the fact that this endocrine population has
reached up to the center of the thyroid lobe along its
phylogenetic evolution, establishing close contact with
follicular cells in a “parafollicular” position (Kalisnik et
al., 1988). Curiously, the central regions of the thyroid
lobes present higher follicular cell activity than the
periphery of the lobes. If this hypothesis is true,
follicular cells should express TRH-Rs for the suggested
paracrine modulation of thyroid hormone secretion
carried out by C-cells. Supporting this idea, similar
models have been recently described outside the nervous
system and pituitary gland, such as testis, adrenal gland,
thymus and other lymphoid tissue, where the expression
of TRH-Rs has been demonstrated, suggesting a
paracrine regulation by TRH in these organs (Satoh et
al., 1994; Mellado et al., 1999; Montagne et al., 1999). 
In order to elucidate whether or not C-cell TRH
production could act over follicular cells modulating
thyroid function, we investigate TRH-Rs expression in
PC C13 follicular cells from rat thyroid, by means of
immunofluorescence technique and RT-PCR analysis.
We also study the possibility that C-cells present TRH-
Rs for the autocrine control of its own TRH production.
Materials and methods
Cell culture
PC C13 cells (generously provided by Dr. Massimo
Santoro, Centro di Endocrinologia e Oncologia
Sperimentale di C.N.R., Naples) were grown in Coon’s
modified Ham’s F12 medium (Sigma) supplemented
with 5% calf serum (Gibco) and a mixture of six growth
factors (10 nM thyrotropin, 10 nM hydrocortisone, 20
mg/ml glycyl-hystidyl-lysine, 10 nM hydrocortisone, 5
mg/ml transferrin, 5 nM somatostatin, and 100 nM
insulin), as previously reported (Florio et al., 2001). Cell
line 6-23 (rat thyroid C-cells; Clone 6, LGC
Promochem-ATCC) was cultured with Dulbecco’s
modified Eagle’s medium with 85% glucose (4.5 g/L),
and 15% horse serum. Cultures were maintained at 37°C
in a humidified atmosphere with 5% CO2. 
RNA Isolation and Reverse Transcription (RT)-PCR
Total RNA from cultured cells was isolated with
Tripure Isolation Reagent (Roche Diagnostics,
Germany). RNA concentration was determined
spectrophotometrically. AMV reverse transcriptase and
random primers from Roche Diagnostics (Germany)
were used for RT-PCR. Five micrograms of RNA were
reverse transcripted with 1st Strand cDNA Synthesis Kit
for RT-PCR (AMV) (Roche Diagnostics, Germany).
Four microlitres from the transcription reaction were
amplified by PCR. A typical 35 cycles amplification was
performed with 1 min denaturation step at 94ºC, 1 min
annealing step at 57°C, and 1 min extension step at




CTGGTGGATCTCAAT-3’; and rTRH-R2-reverse, 5’-
G A G C A G T A C C A G T G T G C G G T A A G - 3 ’
(Basmaciogullari et al., 2000). Primers were located in
different exons to avoid amplification of contaminated
genomic DNA. The products of amplification, 344 bp
for TRH-R1 and 350 bp for TRH-R2, were separated on
a 2% agarose gel. Each experiment was repeated three
times. PCR products were direct sequenced at NBT
(www.newbiotechnic.com) and compared with the
appropriated TRH-R mRNA rat sequences (GeneBank
Accession numbers: NM_013047 for TRH-R1, and
AF149717 for TRH-R2). cDNA from rat brain total
RNA was used as positive control for RT-PCR of both
receptors. Negative controls consisted of omission of
cDNA in the PCR mixture and of the reverse
transcriptase enzime during retrotranscription.
Rat ß-actin mRNA was amplified as RT-PCR
positive control (sense primer: 5’-TTGTAACCAACTG
GGACGATATGG-3’ and antisense primer: 5’-GATCTT
GATCTTCATGGTGCTAGG-3’; leading a fragment of
746 bp). 
Immunofluorescence TRH-R detection
Cells were trypsinized and transferred to a slide-
flask (Labtek slide chamber; Nunc, USA) and incubated
for 24 h. Afterwards, cells where starved in serum-free
and growth factor-free medium for 24 h before
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experiments. For immunofluorescence, slides were
washed three times in PBS and quickly fixed in cold
methanol at -20°C for 6 min. After PBS washing, slides
were blocked with horse serum for 30 min at room
temperature in a humidity chamber. Afterwards,
polyclonal antibodies against the amino terminus of
TRH-R1 (E-16) and TRH-R2 (D-21) of rat origin
(diluted 1:50; Santa Cruz Biotechnology, Inc.) were
added for overnight incubation at 4ºC in a humidity
chamber. DAPI was added to the primary antibody for
nucleus counterstaining. PBS-washed slides were
incubated with donkey anti-goat antibody labeled with
cyanine-2 (Cy2) (diluted 1:100, Jackson Immuno-
research Laboratories) for 45 min at room temperature in
a humidity chamber. After PBS washing, slides were
mounted in 90% glycerol, 2% n-propylgallate (Sigma),
1xPBS, and observed under epi-fluorescence microscope
(Olympus BX50). Negative control reactions for TRH-
Rs were carried out by omitting primary antibodies. 
Results 
The RT-PCR analysis of PC C13 cell line resulted in
the amplification of the specific 350 bp band
corresponding to TRH-R2, but did not yield any band
with the primers for TRH-R1 (Fig. 1A). In the case of 6-
23 C-cells, TRH-R1 and TRH-R2 mRNAs were
demonstrated by this technique with the appearance of
the corresponding 344 bp and 350 bp bands, respectively
(Fig. 1A). The intensities of TRH-Rs PCR bands were
similar to those of rat brain total mRNA, used as positive
controls. The direct sequencing of the PCR products
ensured that amplicons corresponded to rat TRH-Rs
(data not shown).
Immunofluorescence technique was performed in
order to further localize the TRH-R proteins within
individual follicular cells. TRH-R1 immunostainning, as
expected, rendered no fluorescence signals in PC C13
thyroid cells (Fig. 1B). In contrast, TRH-R2 was
detected in the PC C13 cell line as cytoplasmic
immunoreactivity (Fig. 1C). 
Discussion
TRH is synthesized by peptidergic neurons of
supraoptic and paraventricular nuclei of the
hypothalamus, and then axonally transported to be stored
in the median eminence. When secreted in the
bloodstream, it reaches the anterior pituitary where it
stimulates the production of TSH which in turn
stimulates the production of thyroxin (T4) and
triiodothyronine (T3) in the thyroid gland. 
The effects of TRH on thyroid hormone secretion do
not take place only at the pituitary, but also at the
thyroid. It has been demonstrated that high
concentrations of TRH inhibit TSH induced
iodothyronine release and cAMP increase from dog
thyroid, suggesting that TRH in the thyroid participates
in the regulation of thyroid hormone secretion as an
antagonist to TSH (Delbeke et al., 1983; Iversen and
Laurberg, 1985). 
In addition to this point, Rausell et al. (1999) found
that the levels of TRH and TRH-like peptides in the
thyroid were strongly influenced by thyroid status. The
concentrations of TRH in the hyperthyroid and
hypothyroid rats were higher than in the euthyroid rats.
The possibility that TRH and TRH-like peptides act
within the thyroid is also supported by other reports
where exogenous TRH exerted a direct effect on thyroid
hormone release in vitro (Raspe et al., 1991) and
administration of TRH to hyperthyroid patients with
very low levels of TSH resulted in decreased levels of
circulating thyroid hormones (Sato et al., 1995).
Although there is evidence that the thyroid gland
accumulates some TRH from the blood (Steiner et al.,
1974), it is also known that TRH immunoreactivity is
observed in the thyroid, correlating with true TRH gene
expression (Gkonos et al., 1989). This last alternative
opens the possibility of a paracrine regulation of
follicular cell secretion through the releasing of TRH by
neighbor C-cells. 
If the hypothesis of TRH having an additional role
as local regulator of thyroid hormones secretion is true,
follicular cells must contain receptors for TRH. The
present study shows, for the first time, the presence of
TRH-R2 at both mRNA and protein levels in the rat
thyroid follicular cell line PC C13. 
The expression of TRH-R2 in thyroid follicular cells
could explain the influence of thyroidal status on TRH
secretion by C-cells (Rausell et al., 1999). The increased
levels of TRH in experimental hyperthyroid and
hypothyroid rats could be the response to increased
levels of T3 and TSH, respectively. This is also in
accordance with Iversen and Laurberg (1985), who
suggested that TRH in the thyroid participates in the
regulation of thyroid hormone secretion as an antagonist
to TSH. Moreover, the presence of TSH receptors in
thyroid C-cells has been demonstrated by immunocyto-
chemistry (Tamir et al., 1990). As it occurs with several
regulatory peptides in the pituitary (Pazos-Moura et al.,
2003), synthesis of TRH by C-cells seems to be under
hormonal control which is in agreement with the
proposed biological role of local regulators, namely to
modulate or fine-tune the response of the tissue to
hormonal regulation. 
On the other hand, we also described the presence of
TRH-R1 and TRH-R2 in a cell line from rat thyroid C-
cells. It is interesting to consider the possibility of an
autocrine regulation, common in endocrine cells, in the
secretion of TRH by C-cells in the thyroid. Moreover,
the presence of TRH-Rs in rat thyroid C-cells could
explain the calcitonin release from thyroid C-cells after
stimulation with TRH and calcium injection separately
(Oishi et al., 1992). 
TRH-R1 and TRH-R2 exhibit similar binding
affinities for a number of TRH analogs and similar
activation of the phosphoinositide-calcium signal
transduction pathway by TRH (Harder et al., 2001). In
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Fig. 1. TRH-Rs expression in rat thyroid cells at mRNA and protein
levels. A. RT-PCR for TRH-R1 and TRH-R2 in PC C13 follicular cells
and 6-23 C-cells. Rat brain cDNA was used as positive control for both
receptors, and water instead of cDNA as negative control. B. PC C13
cells immunonegative for TRH-R1 antibody. C. Some TRH-R2
immunopositive PC C13 cells revealing the cytoplasmatic distribution of
the receptor. Bar: 10 µm.
contrast, TRH-R2 is more rapidly internalized, more
markedly downregulated, and exhibits greater basal
signaling activity after binding TRH than TRH-R1
(Wang and Gershengorn, 1999; O’Dowd et al., 2000).
Moreover, both receptors present distinct regulation and
anatomic distribution in the rat. The extensive
distribution of TRH-R2 in the brain suggests that it
mediates many of the known functions of TRH that are
not transduced by TRH-R1 (O’Dowd et al., 2000), and
proposes important functional and structural differences
between the two receptors. In the rat thyroid, C-cells
express both TRH-Rs while follicular cells only express
TRH-R2. Although it is only speculation, TRH-R2 from
follicular cells could activate only when exposed to a
high concentration of TRH, as suggested by Iversen and
Laurberg (1985), and this may be due to its higher basal
signaling. TRH for this activation process would be
locally provided by C-cells TRH secretion, since
hypothalamic TRH from the blood stream is present at a
very low concentration in the thyroid (Steiner et al.,
1974). Studies in order to elucidate the role of the
specific TRH-Rs expression in each of the thyroid cell
subtypes were not intended for the purposes of this
paper. 
In conclusion, we have demonstrated that rat thyroid
follicular cells express TRH-R2 at mRNA and protein
level. On the other hand, rat thyroid C-cells express both
receptors, TRH-R1 and TRH-R2. Although further
studies are needed to evaluate the significance of the
different TRH-Rs expression in thyroid cells and the
paracrine/autocrine effects of TRH in the thyroid, our
data provide new evidence for a novel intrathyroidal
regulatory pathway of thyroid hormone secretion via
paracrine/autocrine TRH signaling. 
Acknowledgements. This study was supported by grants from the
Ministerio de Ciencia y Tecnología (ref. BFI2003-0606 and P2003-
1339), and the Secretaría General de Universidad e Investigación of the
Junta de Andalucía (CTS-439 and CTS-0160), Spain.
References
Basmaciogullari A., Cras-Meneur C., Czernichow P. and Scharfmann R.
(2000). Pancreatic pattern of expression of thyrotropin-releasing
hormone during rat embryonic development. J. Endocrinol. 166,
481-488.
Bidaud I., Lory P., Nicolas P., Bulant M. and Ladram A. (2002).
Characterization and functional expression of cDNAs encoding
thyrotropin-releasing hormone receptor from Xenopus laevis. Eur. J.
Biochem. 269, 4566-4576.
Calzá L., Giardino L., Ceccatelli S., Zanni M., Elde R. and Hökfelt T.
(1992). Distribution of thyrotropin-releasing hormone receptor
messenger RNA in the rat brain: an in situ hybridization study.
Neuroscience 51, 891-909.
Cao J., O’Donnell D., Vu H., Payza K., Pou C., Godbout C., Jakob A
Pelletier M., Lembo P., Ahmad S. and Walker P. (1998). Cloning
and characterization of cDNA encoding a novel subtype of rat
thyrotropin-releasing hormone receptor. J. Biol. Chem. 273, 32281-
32287.
De la Pena P., Delgado L.M., Del Camino D. and Barros F. (1992).
Cloning and expression of the thyrotropin-releasing hormone
receptor form GH3 rat anterior pituitary cells. Biochem. J. 284, 891-
899.
Delbeke D., Van Sande J., Cochaux P., Decoster C. and Dumont J.E.
(1983). Effect of thyrotropin-releasing hormone on dog thyroid in
vitro. Biochim. Biophys. Acta 761, 262-268.
Duthie S.M., Taylor P.L., Anderson L., Cook J. and Eidne K.A. (1993).
Cloning and functional characterization of the human TRH receptor.
Mol. Cell Endocrinol. 95, R11-R15.
Florio T., Arena S., Thellung S., Iuliano R., Corsaro A., Massa A.,
Pattarozzi A., Bajetto A., Trapasso F., Fusco A. and Schettini G.
(2001). The activation of the phosphotyrosine phosphatase eta (r-
PTP eta) is responsible for the somatostatin inhibition of PC Cl3
thyroid cell proliferation. Mol. Endocrinol. 15, 1838-1852.
Gkonos P.J., Tavianini M.A., C-C. Liu and Roos B.A. (1989).
Thyrotropin-releasing hormone gene expression in normal thyroid
parafollicular cells. Mol. Endocrinol. 3, 2101-2109.
Griffiths E.C. (1985). Thyrotropin releasing hormone: Endocrine and
central effects. Psychoneuroendocrinology 10, 225-235.
Harder S., Dammann O., Buck F., Zwiers H., Lederis K., Richter D. and
Bruhn T.O. (2001). Cloning of two thyrotropin-releasing hormone
receptor subtypes form a lower vertebrate (Catostomus
commersoni): Functional expression, gene structure, and evolution.
Gen. Comp. Endocrinol. 124, 236-245.
Harder S., Lu X., Wang W., Buck F., Gershengorn M.C. and Bruhn T.O.
(2001). Regulator of G protein signaling 4 suppresses basal and
thyrotropin releasing-hormone (TRH)-stimulated signaling by two
mouse TRH receptors, TRH-R1 and TRH-R2. Endocrinology 142,
1188-1194.
Heuer H., Ehrchen J., Bauer K. and Schäfer M.K.H. (1998). Region-
specific expression of thyrotropin-releasing hormone-degrading
ectoenzyme in the rat central nervous system and pituitary gland.
Eur. J. Neurosci. 10, 1465-1478.
Heuer H., Schäfer M.K.H., O’Donnell D., Walker P. and Bauer K. (2000).
Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in
the central nervous system of rats. J. Comp. Neurol. 428, 319-336.
Horita A. (1998). An update on the CNS actions of TRH and its analogs.
Life Sci. 62, 1443-1448.
Horita A., Carino M.A. and Lai H. (1986). Pharmacology of thyrotropin-
releasing hormone. Annu. Rev. Pharmacol. Toxicol. 26, 311-332. 
Itadani H., Nakamura T., Itoh J., Iwaasa H., Kanatani A., Borkowski J.,
Ihara M. and Ohta M. (1998). Cloning and characterization of a new
subtype of thyrotropin-releasing hormone receptors. Biochem.
Biophys. Res. Commun. 250, 68-71.
Iversen E., Weeke J. and Laurberg P. (1984). TRH immunoreactivity in
the thyroid gland. Scand. J. Clin. Lab. Invest. 44, 703-709. 
Iversen E. and Laurberg P. (1985). Thyrotropin-releasing hormone
(TRH) and hormone secretion from the follicular and C-cells of
perfused dog thyroid lobes. Acta Endocrinol. (Copenh.) 109, 499-
504.
Jackson I.M.D. (1982). Thyrotropin-releasing hormone. N. Engl. J. Med.
306, 145-155.
Kalisnik M., Vraspir-Porenta O., Kham-Lindtner T., Logonder-Mlinsek
M., Pajer Z., Stiblar-Martincic D., Zorc-Pleskovic R. and Trobina M.
(1988). The interdependence of the follicular, parafollicular, and
mast cells in the mammalian thyroid gland: a review and a synthesis.
Am. J. Anat. 183, 148-157.
Kelly J.A. (1995). Thyrotropin-releasing hormone-basis and potential for
its therapeutic use. Essays Biochem. 30, 133-149.
Lechan R.M., Wu P., Jackson I.M.D., Wolf H., Cooperman S., Mandel
G. and Goodman R.H. (1986). Thyrotropin-releasing hormone
precursor: Characterization in rat brain. Science 231, 159-161.
Lu X., Bidaud I., Ladram A. and Gershengorn M.C. (2003).
Pharmacological studies of thyrotropin-releasing hormone (TRH)
receptors from Xenopus leavis: Is xTRHR3 a TRH receptor?
Endocrinology 144, 1842-1846.
Matre V., Karlsen H.E., Wright M.S., Lundell I., Fjeldheim A.K.,
Gabrielsen O.S., Larhammar D. and Gautvik K.M. (1993). Molecular
cloning of a functional human thyrotropin-releasing hormone
receptor. Biochem. Biophys. Res. Commun. 195, 179-185.
Mellado M., Fernandez-Agullo T., Rodriguez-Frade J.M., San Frutos
M.G., de la Pena P., Martinez-A C. and Montoya E. (1999).
Expression analysis of the thyrotropin-releasing hormone receptor
(TRHR) in the immune system using agonist anti-TRHR monoclonal
antibodies. FEBS Lett. 451, 308-314.
Montagne J-J., Ladram A., Grouselle D., Nicolas P. and Bulant M.
(1997). Thyrotropin-releasing hormone immunoreactivity in rat
adrenal tissue is localized in mast cells. J. Histochem. Cytochem.
45, 1623-1627.
Montagne J-J., Ladram A., Nicolas P. and Bulant M. (1999). Cloning of
thyrotropin-releasing hormone precursor and receptor in rat thymus,
adrenal gland, and testis. Endocrinology 140, 1054-1059.
Morley J.E. (1979). Extrahypothalamic thyrotropin-releasing hormone
(TRH)- its distribution and its functions. Life Sci. 25, 1539-1550.
Nillni E.A. and Sevarino K.A. (1999). The biology of pro-thyrotropin-
releasing hormone-derived peptides. Endocrine Rev. 20, 599-648.
O’Dowd B.F., Lee D.K., Huang W., Nguyen T., Cheng R., Liu Y., Wang
B., Gershengorn M.C. and George S.R. (2000). TRH-R2 exhibits
similar binding but distinct regulation and anatomic distribution
compared to TRH-R1. Mol. Endocrinol. 14, 183-193.
Oishi S., Yamauchi J., Fujimoto Y., Hamasaki S., Umeda T. and Sato T.
(1992). Calcitonin release from medullary thyroid carcinoma by
thyrotropin-releasing hormone: comparison with calcium injection.
Acta Endocrinol. 126, 325-328.
Pazos-Moura C.C., Ortiga-Carvalho T.M. and Gaspar de Moura E.
(2003). The autocrine/paracrine regulation of thyrotropin secretion.
Thyroid 13, 167-175.
Pekary A.E., Richkind M. and Hershman J.M. (1983). Thyrotropin-
releasing hormone and related peptides in canine tissues. J.
Endocrinol. 98, 299-306. 
Pekary A.E., Reeve J.R. Jr. and Smith V.P. (1986). Evidence for
thyrotropin-releasing hormone (TRH) biosynthesis in the rat
prostate. Life Sci. 39, 2565-2570.
Prasad C. (1984). Thyrotropin-releasing hormone. In: Handbook of
neurochemistry. Lajtha A. (ed). Plenum Press. New York. pp 175-
200.
Raspe E., Laurent E., Andry G. and Dumont J.E. (1991). ATP,
bradykinin, TRH, and TSH activate the Ca++-phosphatidylinositol
cascade of human thyrocytes in primary culture. Mol. Cell.
Endocrinol. 81, 175-183.
Rausell V., Fraser H.M., Tobaruela M., Del Rio-Garcia J. and Smyth
D.G. (1999). Identification of the TRH-like peptides pGlu-Glu-Pro
amide and pGlu-Phe-Pro amide in rat thyroid: regulation by thyroid
status. Regul. Pept. 81, 55-60.
Sato A., Yamada T., Aizawa T., Ichikawa K., Komiya I., Takasu N. and
Takemura Y. (1995). Effect of thyrotropin-releasing hormone on
717
TRH-R expression in thyroid cell lines
serum thyroid hormones: a study in the patients with untreated and
treated Graves’ disease and subacute thyroiditis. J. Clin. Endocrinol.
Metab. 80, 2173-2177.
Satoh T., Feng P., Kim U.J. and Wilber J.F. (1994). Identification of
thyrotropin-releasing hormone receptor in the rat testis.
Neuropeptides 27, 195-202.
Sellar R.E., Taylor P.L., Lamb R.F., Zabavnik J., Anderson L. and Eidne
K.A. (1993). Functional expression and molecular characterization of
the thyrotropin-releasing hormone receptor from the rat anterior
pituitary gland. J. Mol. Endocrinol. 10, 199-206.
Steiner H., Hünzi H. and Studer R.O. (1974). Accumulation of tritiated
thyrotropin releasing hormone in different organs, especially in the
thyroid. Experientia 30, 1096-1098.
Straub R.E., Frech G.C., Joho R.H. and Gershengorn M.C. (1990).
Expression cloning of a cDNA encoding the mouse pituitary
thyrotropin-releasing hormone receptor. Proc. Natl. Acad. Sci. USA
87, 9514-9518.
Sun Y-M., Millar R.P., Ho H., Gershengorn M.C. and Illing N. (1998).
Cloning and characterization of the chicken thyrotropin-releasing
hormone receptor. Endocrinology 139, 3390-3398.
Takata M., Shimada Y., Ikeda A. and Sekikawa K. (1998). Molecular
cloning of bovine thyrotropin-releasing hormone receptor gene. J.
Vet. Med. Sci. 60, 123-127.
Tamir H., Liu K.P., Hsiung S.C., Adlersberg M., Nunez E.A. and
Gershon M.D. (1990). Multiple signal transduction mechanisms
leading to the secretion of 5-hydroxytryptamine by MTC cells, a
neurectodermally derived cell line. J. Neurosci. 10, 3743-3753.
Wang W. and Gershengorn M.C. (1999). Rat TRH receptor type 2
exhibits higher basal signaling activity than TRH receptor type 1.
Endocrinology 140, 4916-4919.
Yamada M., Monden T., Satoh T., Satoh N., Murakami M., Iriuchijima
T., Kakegawa T. and Mori M. (1993). Pituitary adenomas of patients
with acromegaly express thyrotropin-releasing hormone receptor
messenger RNA: cloning and functional expression of the human
thyrotropin-releasing hormone receptor gene. Biochem. Biophys.
Res. Commun. 195, 737-745.
Zabavnik J., Arbuthnott G. and Eidne K.A. (1993). Distribution of
thyrotropin-releasing hormone receptor messenger RNA in rat
pituitary and brain. Neuroscience 53, 877-887.
Zhao D., Yang J., Jones K.E., Gerald, C., Suzuki Y., Hogan P.G., Chin
W.W. and Tashjian A.H. (1992). Molecular cloning of a
complementary deoxyribonucleic acid encoding the thyrotropin-
releasing hormone receptor and regulation of its messenger
ribonucleic acid in rat GH cells. Endocrinology 130, 3529-3536.
Accepted February 1, 2005
718
TRH-R expression in thyroid cell lines
